Bio-Rad Laboratories Inc (STU:BUWA)
€ 344.3 4.8 (1.41%) Market Cap: 9.37 Bil Enterprise Value: 9.16 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 75/100

Bio Rad Laboratories Inc Investor Day Transcript

Feb 25, 2022 / 03:30PM GMT
Release Date Price: €520 (+0.97%)
Yong Chung
Bio-Rad Laboratories, Inc. - VP of IR

Good morning, everyone. I'm Edward Chung, Head of Investor Relations at Bio-Rad. On behalf of the team, I'm pleased to welcome you to our Investor Day presentation, and this is the most important part from our legal folks.

Before we begin, I'd like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters. These statements are based on assumptions and expectations of future events that are subject to risks and uncertainties. Included in the forward-looking statements are commentary about the impact of COVID-19 pandemic on Bio-Rad's results and operations and steps Bio-Rad is taking in response to the pandemic.

Our actual results may differ materially from these plans and expectations, and the impact and duration of the COVID-19 pandemic is unknown. You should not place undue reliance on these forward-looking statements, and I encourage you to review our filings with the SEC where we discuss in detail the risk factors in our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot